Bank of America
STAB

Bank of America’s Statera Biopharma, Inc. Common Stock STAB Stock Holding History

Bank of America’s Portfolio STAB Stock Details STAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-100
Closed -$8 – 8672
2022
Q4 		$8 Hold
100
– – ﹤0.01% 8112
2022
Q3 		$0 Hold
100
– – ﹤0.01% 8443
2022
Q2 		$0 Hold
100
– – ﹤0.01% 8693
2022
Q1 		$0 Sell
100
-145
-59% -$155 ﹤0.01% 9033
2021
Q4 		$0 Buy
245
+145
+145% +$428 ﹤0.01% 8892
2021
Q3 		$0 Sell
100
-51
-34% -$193 ﹤0.01% 8554
2021
Q2 		$1K Sell
151
-486
-76% -$2.62K ﹤0.01% 7686
2021
Q1 		$4K Buy
637
+537
+537% +$2.94K ﹤0.01% 7160
2020
Q4 		$0 Hold
100
– – ﹤0.01% 7481
2020
Q3 		$0 Sell
100
-11
-10% -$25 ﹤0.01% 7305
2020
Q2 		$0 Buy
111
+11
+11% +$20 ﹤0.01% 7251
2020
Q1 		$0 Sell
100
-3,068
-97% -$6.26K ﹤0.01% 7397
2019
Q4 		$2K Buy
3,168
+2,823
+818% +$2.09K ﹤0.01% 6914
2019
Q3 		$0 Sell
345
-205
-37% -$276 ﹤0.01% 7616
2019
Q2 		$1K Buy
550
+400
+267% +$620 ﹤0.01% 7099
2019
Q1 		$0 Hold
150
– – ﹤0.01% 7519
2018
Q4 		$0 Sell
150
-103
-41% -$178 ﹤0.01% 7492
2018
Q3 		$1K Buy
253
+153
+153% +$328 ﹤0.01% 7178
2018
Q2 		$0 Hold
100
– – ﹤0.01% 7406
2018
Q1 		$0 Hold
100
– – ﹤0.01% 7423
2017
Q4 		$0 Hold
100
– – ﹤0.01% 7343
2017
Q3 		$0 Hold
100
– – ﹤0.01% 7358
2017
Q2 		$0 Hold
100
– – ﹤0.01% 7261
2017
Q1 		$0 Sell
100
-50
-33% -$83 ﹤0.01% 7332
2016
Q4 		$0 Buy
150
+25
+20% +$39 ﹤0.01% 7430
2016
Q3 		$0 Hold
125
– – ﹤0.01% 7444
2016
Q2 		$0 Hold
125
– – ﹤0.01% 7480
2016
Q1 		$0 Hold
125
– – ﹤0.01% 7430
2015
Q4 		$0 Sell
125
-25
-17% -$101 ﹤0.01% 7534
2015
Q3 		$1K Sell
150
-16
-10% -$65 ﹤0.01% 7072
2015
Q2 		$1K Sell
166
-103
-38% -$310 ﹤0.01% 7156
2015
Q1 		$1K Sell
269
-1
-0.4% -$4 ﹤0.01% 6889
2014
Q4 		$2K Hold
270
– – ﹤0.01% 7504
2014
Q3 		$2K Sell
270
-42
-13% -$385 ﹤0.01% 7810
2014
Q2 		$3K Buy
312
+42
+16% +$491 ﹤0.01% 7766
2014
Q1 		$4K Buy
270
+20
+8% +$326 ﹤0.01% 7421
2013
Q4 		$6K Buy
250
+5
+2% +$136 ﹤0.01% 7439
2013
Q3 		$8K Hold
245
– – ﹤0.01% 7257
2013
Q2 		$8K Buy
+245
New +$8.44K ﹤0.01% 7240

Other funds holding STAB

Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
TAM
Tucker Asset Management Littleton, Colorado $343M AUM 17.55% 1-Year Est. Return

Bank of America's STAB Position: Q1 2023 in Review

Bank of America sold out of Statera Biopharma, Inc. Common Stock (STAB) in Q1 2023, closing a stake of 100 shares — an estimated $8 sold.

Bank of America first reported a position in STAB in Q2 2013 and held it in 39 quarters. The position peaked at $8K in Q3 2013. 4 funds tracked by Wall St. Rank hold STAB as of Q1 2023.

  • Bank of America reported no remaining Statera Biopharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Bank of America sold 100 Statera Biopharma, Inc. Common Stock shares in Q1 2023, an estimated $8.
  • Bank of America first reported a position in Statera Biopharma, Inc. Common Stock in Q2 2013 and held it in 39 quarters.
  • Bank of America's Statera Biopharma, Inc. Common Stock position peaked at $8K in Q3 2013.
  • 4 funds tracked by Wall St. Rank held Statera Biopharma, Inc. Common Stock as of Q1 2023.

Based on Bank of America's 13F filing for Q1 2023, filed 12 May 2023.